Actions of adenosine at its receptors in the CNS: Insights from knockouts and drugs

被引:278
作者
Fredholm, BB [1 ]
Chen, JF
Masino, SA
Vaugeois, JM
机构
[1] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden
[2] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA
[3] Trinity Coll, Dept Psychol, Hartford, CT 06106 USA
[4] Trinity Coll, Neurosci Program, Hartford, CT 06106 USA
[5] Fac Med & Pharm, CNRS, FRE2735, IFRMP 23, F-76183 Rouen, France
关键词
A1; receptor; A2A receptor; caffeine; ischemia; Parkinson's disease; pain;
D O I
10.1146/annurev.pharmtox.45.120403.095731
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine and its receptors have been the topic of many recent reviews (1-26). These reviews provide a good summary of much of the relevant literature-including the older literature. We have, therefore, chosen to focus the present review on the insights gained from recent studies on genetically modified mice, particularly with respect to the function of adenosine receptors and their potential as therapeutic targets. The information gained from studies of drug effects is discussed in this context, and discrepancies between genetic and pharmacological results are highlighted.
引用
收藏
页码:385 / 412
页数:28
相关论文
共 158 条
  • [81] Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD
    Hauser, RA
    Hubble, JP
    Truong, DD
    [J]. NEUROLOGY, 2003, 61 (03) : 297 - 303
  • [82] Acute adenosinergic cardioprotection in ischemic-reperfused hearts
    Headrick, JP
    Hack, B
    Ashton, KJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (05): : H1797 - H1818
  • [83] Gαolf levels are regulated by receptor usage and control dopamine and adenosine action in the striatum
    Hervé, D
    Le Moine, C
    Corvol, JC
    Belluscio, L
    Ledent, C
    Fienberg, AA
    Jaber, M
    Studler, JM
    Girault, JA
    [J]. JOURNAL OF NEUROSCIENCE, 2001, 21 (12) : 4390 - 4399
  • [84] Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy
    Huber, A
    Padrun, V
    Déglon, N
    Aebischer, P
    Möhler, H
    Boison, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) : 7611 - 7616
  • [85] Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease
    Ikeda, K
    Kurokawa, M
    Aoyama, S
    Kuwana, Y
    [J]. JOURNAL OF NEUROCHEMISTRY, 2002, 80 (02) : 262 - 270
  • [86] IMAIZUMI M, 1994, METHOD FIND EXP CLIN, V16, P639
  • [87] Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex
    Iwasato, T
    Datwani, A
    Wolf, AM
    Nishiyama, H
    Taguchi, Y
    Tonegawa, S
    Knöpfel, T
    Erzurumlu, RS
    Itohara, S
    [J]. NATURE, 2000, 406 (6797) : 726 - 731
  • [88] ANXIOLYTIC ACTIVITY OF ADENOSINE RECEPTOR ACTIVATION IN MICE
    JAIN, N
    KEMP, N
    ADEYEMO, O
    BUCHANAN, P
    STONE, TW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (03) : 2127 - 2133
  • [89] Adenosine A2A receptor gene disruption provokes marked changes in melanocortin content and pro-opiomelanocortin gene expression
    Jégou, S
    Yacoubi, ME
    Mounien, L
    Ledent, C
    Parmentier, M
    Costentin, J
    Vaugeois, JM
    Vaudry, H
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2003, 15 (12) : 1171 - 1177
  • [90] Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation
    Jin, XW
    Shepherd, RK
    Duling, BR
    Linden, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) : 2849 - 2857